Related Experiment Videos
Coagulation abnormalities in patients with hip osteonecrosis
Anastasios V Korompilias1, Thomas L Ortel, James R Urbaniak
1Department of Orthopaedic Surgery, University of Ioannina School of Medicine, Ioannina, 45110, Greece. koroban@otenet.gr
The Orthopedic Clinics of North America
|July 24, 2004
Summary
Patients with hip osteonecrosis often have coagulation abnormalities, increasing their risk for bone necrosis through blood clots. Identifying hypercoagulability early may allow interventions to prevent this condition.
Area of Science:
- Orthopedics
- Hematology
- Vascular Biology
Background:
- Hip osteonecrosis is a debilitating condition.
- Coagulation abnormalities are frequently observed in patients with osteonecrosis.
- These abnormalities may predispose patients to thromboembolic events.
Purpose of the Study:
- To investigate the association between coagulation abnormalities and hip osteonecrosis.
- To highlight the potential role of hypercoagulability in the pathogenesis of bone necrosis.
- To emphasize the importance of early diagnosis and intervention.
Main Methods:
- Review of patient data with hip osteonecrosis.
- Assessment of hemostatic parameters.
- Analysis of thromboembolic event frequency.
Main Results:
- A high frequency of coagulation abnormalities was noted in patients with hip osteonecrosis.
- These abnormalities are linked to an increased risk of thromboembolic phenomena.
- The association between osteonecrosis and hypercoagulability is increasingly recognized.
Conclusions:
- Coagulation disorders are significant risk factors for hip osteonecrosis development.
- Early detection of hypercoagulability in at-risk patients is crucial.
- Pharmacologic intervention may prevent the progression of osteonecrosis.